MedPath

The value of a molecular diagnostic tool in patients with suspect pancreatic cancer

Recruiting
Conditions
Pancreatic CancerPeriampullary CancerPancreas kankerPeriampullaire kanker
Registration Number
NL-OMON23289
Lead Sponsor
eiden University Medical CenterDepartment of Surgery and department of Pathology
Brief Summary

Prior publication: https://www.ncbi.nlm.nih.gov/pubmed/28775172

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
57
Inclusion Criteria

•Patient with suspect pancreatic or periampullary lesion (papil; duodenum; distal bile duct); or patients with suspect cysts

•Sufficient radiological images; assessed by specialized radiologist

Exclusion Criteria

none

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Diagnostic accuracy of NGS
Secondary Outcome Measures
NameTimeMethod
- Contribution of NGS to the diagnostic process.<br /><br>- Percentage of change of treatment type<br /><br>- Sensitivity and specificity
© Copyright 2025. All Rights Reserved by MedPath